HMGB1 and neoplasm: We speculate that this may reflect a non-productive ICD phenotype, wherein tumor cells emit ICD-associated signals (e.g., calreticulin, HMGB1) but fail to initiate effective immune clearance due to a profoundly immunosuppressive microenvironment.